The serostatus approach to fighting the HIV epidemic: Prevention strategies for infected individuals

被引:329
作者
Janssen, RS [1 ]
Holtgrave, DR [1 ]
Valdiserri, RO [1 ]
Shepherd, M [1 ]
Gayle, HD [1 ]
De Cock, KM [1 ]
机构
[1] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA
关键词
D O I
10.2105/AJPH.91.7.1019
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In the United States, HIV prevention programs have historically tailored activities for specific groups primarily on the basis of behavioral risk factors and demographic characteristics. Through the Serostatus Approach to Fighting the Epidemic (SAFE), the Centers for Disease Control and Prevention is now expanding prevention programs, especially for individuals with HIV to reduce the risk of transmission as a supplement to current programs that primarily focus on reducing the risk of acquisition of the virus. For individuals with HIV, SAFE comprises action steps that focus on diagnosing all HIV-infected persons, linking them to appropriate high-quality care and prevention services, helping them adhere to treatment regimens, and supporting them in adopting and sustaining HIV risk reduction behavior. SAFE couples a traditional infectious disease control focus on the infected person with behavioral interventions that have been standard for MV prevention programs.
引用
收藏
页码:1019 / 1024
页数:6
相关论文
共 60 条
  • [51] Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand
    Shaffer, N
    Roongpisuthipong, A
    Siriwasin, W
    Chotpitayasunondh, T
    Chearskul, S
    Young, NL
    Parekh, B
    Mock, PA
    Bhadrakom, C
    Chinayon, P
    Kalish, ML
    Phillips, SK
    Granade, TC
    Subbarao, S
    Weniger, BG
    Mastro, TD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (03) : 590 - 599
  • [52] Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial
    Shaffer, N
    Chuachoowong, R
    Mock, PA
    Bhadrakom, C
    Siriwasin, W
    Young, NL
    Chotpitayasunondh, T
    Chearskul, S
    Roongpisuthipong, A
    Chinayon, P
    Karon, J
    Mastro, TD
    Simonds, RJ
    [J]. LANCET, 1999, 353 (9155) : 773 - 780
  • [53] Sodora DL, 1998, AIDS RES HUM RETROV, V14, pS119
  • [54] Field evaluation of rapid HIV serologic tests for screening and confirming HIV-1 infection in Honduras
    Stetler, HC
    Granade, TC
    Nunez, CA
    Meza, R
    Terrell, S
    Amador, L
    George, JR
    [J]. AIDS, 1997, 11 (03) : 369 - 375
  • [55] Promoting early HIV diagnosis and entry into care
    Valdiserri, RO
    Holtgrave, DR
    West, GR
    [J]. AIDS, 1999, 13 (17) : 2317 - 2330
  • [56] Effect of antiviral treatment on the shedding of HIV-1 in semen
    Vernazza, PL
    Gilliam, BL
    Flepp, M
    Dyer, JR
    Frank, AC
    Fiscus, SA
    Cohen, MS
    Eron, JJ
    [J]. AIDS, 1997, 11 (10) : 1249 - 1254
  • [57] Quantification of HIV in semen: Correlation with antiviral treatment and immune status
    Vernazza, PL
    Gilliam, BL
    Dyer, J
    Fiscus, SA
    Eron, JJ
    Frank, AC
    Cohen, MS
    [J]. AIDS, 1997, 11 (08) : 987 - 993
  • [58] SEXUAL-BEHAVIOR OF INDIVIDUALS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS - THE NEED FOR INTERVENTION
    WENGER, NS
    KUSSELING, FS
    BECK, K
    SHAPIRO, MF
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (16) : 1849 - 1854
  • [59] WIKTOR SZ, 1990, J ACQ IMMUN DEF SYND, V3, P62
  • [60] Human immunodeficiency virus type I in the semen of men receiving highly active antiretroviral therapy
    Zhang, H
    Dornadula, G
    Beumont, M
    Livornese, L
    Van Uitert, B
    Henning, K
    Pomerantz, RJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (25) : 1803 - 1809